Leaping into the Future: Genetic Testing and Acute Lymphocytic Leukemia Susceptibility
Unlock the potential of genetic testing in acute lymphocytic leukemia management. Discover personalized treatments, relapse risk, and family screening insights.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Lymphoproliferative Syndrome 1: Unlocking the Genetic Code for Better Diagnosis and Treatment
Genetic testing revolutionizes XLP1 diagnosis and treatment. Learn about SH2D1A gene mutations, tailored therapies, and insights for informed family planning.
Lynch Syndrome 8: Unraveling the Genetic Threads of a Hereditary Cancer Syndrome
Genetic testing crucial for Lynch Syndrome 8, enabling early cancer detection, personalized management, and family risk assessment to prevent hereditary cancer.
Maturity-Onset Diabetes of the Young Type 10: Unlocking the Genetic Code
Explore how genetic testing aids in diagnosing MODY10, offering personalized treatment plans, enhancing family planning, and advancing diabetes research and understanding.
Making Sense of Maturity-Onset Diabetes of the Young Type 11: The Role of Genetic Testing
Unlock the potential of genetic testing in diagnosing and treating MODY 11. Gain insights into genetic mutations, personalized treatment, and disease progression.
Melanoma, Cutaneous Malignant, Susceptibility to, 5: Decoding the Genetic Blueprint
Genetic testing identifies mutations linked to melanoma risk, enabling personalized prevention and treatment strategies, transforming melanoma management.
Metaphyseal Anadysplasia 2: Unraveling the Genetic Code for Better Diagnosis and Management
Explore how genetic testing reveals mutations in Metaphyseal Anadysplasia 2, offering early diagnosis, guiding treatment, and aiding family planning decisions.
Microcephaly, Seizures, and Developmental Delay: Unraveling the Genetic Threads
Explore how genetic testing aids in diagnosing microcephaly, seizures, and developmental delays, guiding treatment, family planning, and enhancing research insights.